Hap Trading, LLC Mirati Therapeutics, Inc. Put Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $1.09 Million - $2.59 Million	26,300 New	26,300 $280,000
Q1 2020 May 08, 2020	BUY	$69.78 - $116.21 $153,516 - $255,662	2,200 Added 5.77%	40,300 $130,000
Q3 2019 Nov 12, 2019	SELL	$77.91 - $109.6 $1.98 Million - $2.78 Million	-25,400 Reduced 40.0%	38,100 $182,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $3.78 Million - $6.65 Million	63,500 New	63,500 $203,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.